Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus

INTRODUCTION: There is limited data on the analytical performance of commercial nucleic acid tests (NATs) for laboratory confirmation of COVID-19 infection. METHODS: Nasopharyngeal, combined nose and throat swabs, nasopharyngeal aspirates and sputum was collected from persons with suspected SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, H., Carter, I., Basile, K., Donovan, L., Kumar, S., Tran, T., Ko, D., Alderson, S., Sivaruban, T., Eden, J.-S., Rockett, R., O’Sullivan, M.V., Sintchenko, V., Chen, S.C-A., Maddocks, S., Dwyer, D.E., Kok, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195305/
https://www.ncbi.nlm.nih.gov/pubmed/32361322
http://dx.doi.org/10.1016/j.jcv.2020.104374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195305/
https://www.ncbi.nlm.nih.gov/pubmed/32361322
http://dx.doi.org/10.1016/j.jcv.2020.104374

Ejemplares similares